کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3334616 1213454 2013 13 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
HER2 Assessment in Upper Gastrointestinal Tract Adenocarcinoma
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی هماتولوژی
پیش نمایش صفحه اول مقاله
HER2 Assessment in Upper Gastrointestinal Tract Adenocarcinoma
چکیده انگلیسی
Gastric and gastroesophageal junction adenocarcinomas constitute a major health problem. For localized disease, adjuvant treatment is multidisciplinary and usually includes a combination of surgery, radiation and chemotherapy. Recently, trastuzumab (Herceptin) has been approved for the treatment of metastatic upper gastrointestinal (GI) tract (gastric, esophageal, and gastroesophageal) adenocarcinomas. The purpose of this review is to provide pathologists with practical guidance in HER2 assessment of upper GI tract adenocarcinomas in order to accurately identify patients eligible for trastuzumab therapy.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Surgical Pathology Clinics - Volume 6, Issue 3, September 2013, Pages 391-403
نویسندگان
, ,